T cell immunomodulation by clinically used allogeneic human cancellous bone fragments: a potential novel immunotherapy tool
Sign Up to like & getrecommendations! Published in 2018 at "Scientific Reports"
DOI: 10.1038/s41598-018-31979-1
Abstract: Multipotential stromal cells (MSCs) demonstrate strong immunomodulation capabilities following culture expansion. We have previously demonstrated that human cancellous bone fragments (CBFs) clinically used as viable allografts for spinal fusion have resident MSCs that exhibit T… read more here.
Keywords: clinically used; human cancellous; immunomodulation; cancellous bone ... See more keywords